Krankenhaus und Poliklinik Ruedersdorf GmbH
- Address
- lock Available on a paid plan
Immune System Diseases and Musculoskeletal Diseases
At Krankenhaus und Poliklinik Ruedersdorf GmbH, clinical research in these areas focuses on chronic inflammatory demyelinating polyneuropathy and inclusion body myositis. The studies are designed to assess whether new treatments can improve symptoms, slow disease activity, and offer better control of these complex conditions.
- Evaluating a new therapy for inclusion body myositis to understand its impact on function and safety
- Studying treatment effectiveness in chronic inflammatory demyelinating polyneuropathy with a focus on reducing relapse
This work reflects a specialized interest in neurology and pain therapy, with research aimed at improving care for patients living with rare immune-related and muscle disorders.
Neurology and Rare Neuromuscular Disorders
The site is conducting targeted trials for adults affected by inclusion body myositis and chronic inflammatory demyelinating polyneuropathy. These studies are intended to test whether new approaches can support disease control, improve daily physical abilities, and provide useful safety information for future treatment options.
- Testing a potential therapy for inclusion body myositis to measure functional benefit
- Assessing a treatment for chronic inflammatory demyelinating polyneuropathy to compare outcomes with placebo
With a small but focused research portfolio, the Rüdersdorf clinic contributes to clinical development in difficult-to-treat neuromuscular diseases and related immune-mediated conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Dianthus Therapeutics Inc.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Krankenhaus und Poliklinik Ruedersdorf GmbH
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase II/III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Determine the Efficacy and Safety of ABC008 in the Treatment of Subjects with Inclusion Body Myositis | Abcuro Inc. | Phase IV | Not Recruiting | Jan 2024 | Nov 2025 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dnth103 | 1 | Unknown | 2025-08-04 | 2025-08-04 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.